These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32470537)

  • 1. Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair.
    Iliadis C; Metze C; Körber MI; Baldus S; Pfister R
    Int J Cardiol; 2020 Oct; 316():189-194. PubMed ID: 32470537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
    Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW;
    JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
    Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
    Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
    Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial.
    Saxon JT; Cohen DJ; Chhatriwalla AK; Kotinkaduwa LN; Kar S; Lim DS; Abraham WT; Lindenfeld J; Mack MJ; Arnold SV; Stone GW
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2795-2803. PubMed ID: 33303119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial.
    Asch FM; Grayburn PA; Siegel RJ; Kar S; Lim DS; Zaroff JG; Mishell JM; Whisenant B; Mack MJ; Lindenfeld J; Abraham WT; Stone GW; Weissman NJ;
    J Am Coll Cardiol; 2019 Dec; 74(24):2969-2979. PubMed ID: 31574303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation.
    Malik UI; Ambrosy AP; Ku IA; Mishell JM; Kar S; Lim DS; Whisenant BK; Cohen DJ; Arnold SV; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2020 Oct; 13(20):2331-2341. PubMed ID: 33092707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.
    Koell B; Orban M; Weimann J; Kassar M; Karam N; Neuss M; Petrescu A; Iliadis C; Unterhuber M; Adamo M; Giannini C; Melica B; Ludwig S; Massberg S; Praz F; Pfister R; Thiele H; Stephan von Bardeleben R; Baldus S; Butter C; Lurz P; Windecker S; Metra M; Petronio AS; Hausleiter J; Lubos E; Kalbacher D;
    J Am Coll Cardiol; 2021 Dec; 78(24):2408-2421. PubMed ID: 34886961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT Trial.
    Arnold SV; Stone GW; Mack MJ; Chhatriwalla AK; Austin BA; Zhang Z; Ben-Yehuda O; Kar S; Lim DS; Lindenfeld J; Abraham WT; Cohen DJ;
    J Am Coll Cardiol; 2020 May; 75(17):2099-2106. PubMed ID: 32194195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation.
    Adamo M; Fiorelli F; Melica B; D'Ortona R; Lupi L; Giannini C; Silva G; Fiorina C; Branca L; Chiari E; Chizzola G; Spontoni P; Espada Guerreiro C; Curello S; Petronio AS; Metra M
    JACC Cardiovasc Interv; 2021 Jan; 14(1):15-25. PubMed ID: 33309313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison.
    Ludwig S; Conradi L; Cohen DJ; Coisne A; Scotti A; Abraham WT; Ben Ali W; Zhou Z; Li Y; Kar S; Duncan A; Lim DS; Adamo M; Redfors B; Muller DWM; Webb JG; Petronio AS; Ruge H; Nickenig G; Sondergaard L; Adam M; Regazzoli D; Garatti A; Schmidt T; Andreas M; Dahle G; Walther T; Kempfert J; Tang GHL; Redwood S; Taramasso M; Praz F; Fam N; Dumonteil N; Obadia JF; von Bardeleben RS; Rudolph TK; Reardon MJ; Metra M; Denti P; Mack MJ; Hausleiter J; Asch FM; Latib A; Lindenfeld J; Modine T; Stone GW; Granada JF;
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e013045. PubMed ID: 37194288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility to COAPT trial in the daily practice: A real-world experience.
    Zancanaro E; Buzzatti N; Denti P; Guicciardi NA; Melillo E; Monaco F; Agricola E; Ancona F; Alfieri O; De Bonis M; Maisano F
    Catheter Cardiovasc Interv; 2024 Aug; 104(2):368-377. PubMed ID: 38923261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    Ben-Yehuda O; Shahim B; Chen S; Liu M; Redfors B; Hahn RT; Asch FM; Weissman NJ; Medvedofsky D; Puri R; Kapadia S; Sannino A; Grayburn P; Kar S; Lim S; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Dec; 76(22):2595-2606. PubMed ID: 33243380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.
    Anker SD; Friede T; von Bardeleben RS; Butler J; Khan MS; Diek M; Heinrich J; Geyer M; Placzek M; Ferrari R; Abraham WT; Alfieri O; Auricchio A; Bayes-Genis A; Cleland JGF; Filippatos G; Gustafsson F; Haverkamp W; Kelm M; Kuck KH; Landmesser U; Maggioni AP; Metra M; Ninios V; Petrie MC; Rassaf T; Ruschitzka F; Schäfer U; Schulze PC; Spargias K; Vahanian A; Zamorano JL; Zeiher A; Karakas M; Koehler F; Lainscak M; Öner A; Mezilis N; Theofilogiannakos EK; Ninios I; Chrissoheris M; Kourkoveli P; Papadopoulos K; Smolka G; Wojakowski W; Reczuch K; Pinto FJ; Zmudka K; Kalarus Z; Adamo M; Santiago-Vacas E; Ruf TF; Gross M; Tongers J; Hasenfuß G; Schillinger W; Ponikowski P
    Eur J Heart Fail; 2024 Jul; 26(7):1608-1615. PubMed ID: 38847420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.
    Grayburn PA; Sannino A; Cohen DJ; Kar S; Lim DS; Mishell JM; Whisenant BK; Rinaldi MJ; Kapadia SR; Rajagopal V; Crowley A; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Sep; 76(9):1007-1014. PubMed ID: 32854834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial.
    Giustino G; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Cohen DJ; Kotinkaduwa LN; Weissman NJ; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2020 Oct; 13(20):2317-2328. PubMed ID: 33092705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.
    Goel K; Lindenfeld J; Makkar R; Naik H; Atmakuri S; Mahoney P; Morse MA; Thourani VH; Yadav P; Batchelor W; Rogers J; Whisenant B; Rinaldi M; Hermiller J; Lindman BR; Barker CM
    J Am Coll Cardiol; 2023 Sep; 82(13):1281-1297. PubMed ID: 37730284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial.
    Gertz ZM; Herrmann HC; Lim DS; Kar S; Kapadia SR; Reed GW; Puri R; Krishnaswamy A; Gersh BJ; Weissman NJ; Asch FM; Grayburn PA; Kosmidou I; Redfors B; Zhang Z; Abraham WT; Lindenfeld J; Stone GW; Mack MJ
    Circ Cardiovasc Interv; 2021 Apr; 14(4):e010300. PubMed ID: 33719505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.